Chen F Y, Harris L C, Remack J S, Brent T P
Department of Molecular Pharmacology, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105, USA.
Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4348-53. doi: 10.1073/pnas.94.9.4348.
O6-Methylguanine-DNA methyltransferase (MGMT), an enzyme that repairs adducts at O6 of guanine in DNA, is a major determinant of susceptibility to simple methylating carcinogens or of tumor response to anticancer chloroethylating drugs. To investigate the mechanisms underlying cellular expression of this DNA repair enzyme, we focused on the role of a 59-bp enhancer of the human MGMT gene in the regulation of its expression. By using chloramphenicol acetyltransferase reporter assays, we found that the enhancer activity, which was present in both MGMT-expressing (Mer+) and -deficient (Mer-) cells, correlated with the endogenous MGMT activity in Mer+ cell lines. Band-shift assays and deletion analysis of the 59-bp sequence defined a minimal 9-mer cis element (5'-CTGGGTCGC-3') for specific trans factor binding. The MGMT enhancer binding protein (MEBP), 45 kDa by Southwestern blot analysis, was present in the nuclei of all Mer+ cells tested but was apparently restricted to the cytoplasm of Mer- cells. We conclude that the MEBP-enhancer interaction plays an important role in regulating constitutive MGMT expression in Mer+ cells and that MEBP exclusion from the nucleus may account for the down-regulation of MGMT in Mer- cells.
O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)是一种修复DNA中鸟嘌呤O6位加合物的酶,是对简单甲基化致癌物易感性或肿瘤对抗癌氯乙基化药物反应的主要决定因素。为了研究这种DNA修复酶细胞表达的潜在机制,我们重点关注了人类MGMT基因一个59bp增强子在其表达调控中的作用。通过使用氯霉素乙酰转移酶报告基因检测,我们发现该增强子活性在MGMT表达阳性(Mer+)和阴性(Mer-)细胞中均存在,且与Mer+细胞系中的内源性MGMT活性相关。凝胶迁移试验和对59bp序列的缺失分析确定了一个最小的9聚体顺式元件(5'-CTGGGTCGC-3')用于特异性反式因子结合。通过蛋白质免疫印迹分析,MGMT增强子结合蛋白(MEBP)为45kDa,存在于所有检测的Mer+细胞的细胞核中,但显然仅限于Mer-细胞的细胞质中。我们得出结论,MEBP与增强子的相互作用在调节Mer+细胞中MGMT的组成型表达中起重要作用,并且MEBP被排除在细胞核外可能是Mer-细胞中MGMT下调的原因。